Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Scott Sinclair and Laurence Chang

Page 1 of 2

The under-performance of the hedge fund industry over the past several years has resulted in many hedge funds closing shop. So, it wasn’t a surprise when it was revealed that Cascabel Management L.P., a fund started by former Tiger Management LLC analyst Scott Sinclair, along with Laurence Chang is in the process of shutting down after suffering significant losses in the past few quarters. Cascabel was started in the midst of the financial crisis and had the backing of hedge fund legend Julian Robertson, who through his hedge fund Tiger Management LLC seeded Cascabel. Although Cascabel started on solid footing by generating 29% returns in 2009, it failed to generate consistent returns for its investors. After losing almost 18% in 2011, the fund recovered and was up 4.8% and 27% in 2012 and 2013 respectively. However, it again lost 17% in 2014 and according to reports was down during 2015 as well. Overall, since it was founded, Cascabel Management L.P. provided its investors a meagre return of only 5%. In this article we are going to evaluate Cascabel’s final top stock picks, revealed by the fund’s 13F filing with the Securities and Exchange Commission for the March 31 reporting period. Cascabel’s latest 13F filing reveals that its public equity portfolio held value of only $42.37 million as of March 31, significantly below the $350 million it managed during its peak. The fund was heavily invested in the technology sector, which comprised more than 50% of its public equity portfolio. Cascabel heavily invested in blue chip stocks, as demonstrated by its latest top three stock picks: Time Warner Inc (NYSE:TWX), Google Inc (NASDAQ:GOOGL), and Apple Inc.(NASDAQ:AAPL).

Apple Inc. (NASDAQ:AAPL), Logo, Sign on a building, brand, company, architecture

pio3 /

Before we proceed to evaluate Cascabel’s top stock picks, investors need to sit back and ask themselves why a fund like Cascabel, which mostly invested in large-cap blue chip names had to shut down when most experts argue that blue chips are the best equity investments for individual investors. Research done by Insider Monkey for the period between 1999 and 2012 has shown that contrary to popular belief, the most popular large-cap picks of hedge funds in that period underperformed the broader market by seven basis points per month on average, whereas the 15 most popular small-cap picks outperformed the broader market by an average of nearly one percentage point per month. Insider Monkey’s flagship small-cap strategy has returned over 142%  since its inception in August 2012, outperforming the S&P 500 ETF (SPY) by more than 83% (read the details here).

Scott Sinclair And Laurence Chang
Scott Sinclair And Laurence Chang
Cascabel Management

Cascabel doubled its stake in its top pick Time Warner Inc (NYSE:TWX) during the first quarter to 60,000 shares valued at $5.07 million as of March 31. Shares of Time Warner Inc (NYSE:TWX) have been on a consistent uptrend, up by over 175% in the last five years and by more than 27% over the last year. The company recently priced in a $2.1 billion debt offering and shares are up marginally this year. Most of the analyst community is bullish on the stock, with an average recommendation of ‘Buy’. Currently, Time Warner Inc (NYSE:TWX) shares are trading at $87.22, almost 10% below analysts’ average price target of $96.76. Daniel S. Och’s OZ Management is also heavily bullish on the stock, increasing its stake by 61% to 9.06 million shares in the first quarter.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!